LCM
ORIC icon

Laurion Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Laurion Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,940
Closed -$53K – 579
2022
Q2 		$53K Buy
+11,940
New +$47.6K ﹤0.01% 421
2022
Q1 		– Sell
-47,821
Closed -$703K – 664
2021
Q4 		$703K Hold
47,821
– – 0.01% 380
2021
Q3 		$1M Sell
47,821
-13,155
-22% -$267K ﹤0.01% 512
2021
Q2 		$1.08M Sell
60,976
-16,024
-21% -$351K 0.01% 430
2021
Q1 		$1.89M Sell
77,000
-19,536
-20% -$617K 0.01% 435
2020
Q4 		$3.27M Buy
96,536
+19,536
+25% +$561K 0.03% 289
2020
Q3 		$1.93M Hold
77,000
– – 0.02% 320
2020
Q2 		$2.6M Buy
+77,000
New +$2.46M 0.03% 301

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Laurion Capital Management's ORIC Position: Q3 2022 in Review

Laurion Capital Management sold out of Oric Pharmaceuticals (ORIC) in Q3 2022, closing a stake of 11,940 shares — an estimated $53K sold.

Laurion Capital Management first reported a position in ORIC in Q2 2020 and held it in 8 quarters. The position peaked at $3.27M in Q4 2020. 76 funds tracked by Wall St. Rank hold ORIC as of Q3 2022.

  • Laurion Capital Management reported no remaining Oric Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Laurion Capital Management sold 11,940 Oric Pharmaceuticals shares in Q3 2022, an estimated $53K.
  • Laurion Capital Management first reported a position in Oric Pharmaceuticals in Q2 2020 and held it in 8 quarters.
  • Laurion Capital Management's Oric Pharmaceuticals position peaked at $3.27M in Q4 2020.
  • 76 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2022.

Based on Laurion Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.